Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 8, 2009, Pages 2850-2856

  Nomura, Kaoru ^a   Kimura, Hironari ^a   Shimizu, Satoru ^a   Kodama, Hitomi ^a   Okamoto, Takahiro ^a   Obara, Takao ^a   Takano, Kazue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 68549096021     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2697     Document Type: Article

References (14)

1. Sisson JC, Shulkin BL, Esfandiari NH 2006 Courses of malignant pheochromocytoma. Implication for therapy. Ann NY Acad Sci 1073:505-511
2. Huang KH, Chung SD, Chen SC, Chueh SC, Pu YS, Lai MK, Lin WC 2007 Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute. Int J Urol 14:181-185
3. Bravo EL, Tagle R 2003 Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 24:539-553
4. Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK 2006 Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). Ann NY Acad Sci 1073:465-490
5. Scholz T, Eisenhofer G, Pacak K, Dralle H, Lehnert H 2007 Clinical review: current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab 92:1217-1225
6. Ito Y, Obara T, Okamoto T, Kanbe M, Tanaka R, Iihara M, Okamoto J, Yamazaki K, Jibiki K 1998 Efficacy of single-voided urine metanephrine and normetanephrine assay for diagnosing pheochromocytoma. World J Surg 22:684-688
7. Keiser HR, Goldstein DS, Wade JL, Douglas FL, Averbuch SD 1985 Treatment of malignant pheochromocytoma with combination chemotherapy. Hypertension 7(3 Pt 2):118-124
8. 131I- metaiodobenzylguanidine and α-methyl-p-tyrosine. Jpn J Med 29:329-333
9. Loh KC, Fitzgerald PA, Matthay KK, Yeo PP, Price DC 1997 The treatment of malignant pheochromocytoma with iodo-131-metabenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 20:648-658
10. John H, Ziegler WH, Hauri D, Jaeger P 1999 Pheochromocytoma: can malignant potential be predicted? Urology 53:679-683
11. Wängberg B, Muth A, Khorram-Manesh A, Jansson S, Nilsson O, Forssell-Aronsson E, Tisell L, Ahlman H 2006 Malignant pheochromocytoma in a population-based study. Survival and clinical results. Ann NY Acad Sci 1073:512-516
12. Eisenhofer G, Bornstein SR, Brouwers FM, Cheung NK, Dahia PL, de Krijger RR, Giordano TJ, Greene LA, Goldstein DS, Lehnert H, Manger WM, Maris JM, Neumann HP, Pacak K, Shulkin BL, Smith DI, Tischler AS, Young Jr WF 2004 Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 11:423-436
13. Kimura N, Watanabe T, Noshiro T, Shizawa S, Miura Y 2005 Histological grading of adrenal and extra-adrenal pheochromocytoma and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytoma and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 16:23-32
14. Wakelee HA, Wang W, Schiller JH, Langer CJ, Sandler AB, Belani CP, Johnson DH, for the Eastern Cooperative Oncology Group 2006 Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594. J Thorac Oncol 1:441-446